Tygh Capital Management’s Core Laboratories CLB Stock Holding History

Tygh Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-39,178	Closed	-$1.83M	–	78
2019 Q3	$1.83M	Sell	39,178 -68	-0.2%	-$3.16K	0.32%	74
2019 Q2	$2.05M	Sell	39,246 -6,310	-14%	-$370K	0.35%	76
2019 Q1	$3.14M	Buy	+45,556	New	+$3.05M	0.55%	69
2017 Q3	–	Sell	-13,771	Closed	-$1.4M	–	90
2017 Q2	$1.4M	Sell	13,771 -256	-2%	-$27.6K	0.32%	83
2017 Q1	$1.62M	Sell	14,027 -11,981	-46%	-$1.39M	0.38%	83
2016 Q4	$3.12M	Buy	+26,008	New	+$2.88M	0.78%	61
2014 Q4	–	Sell	-3,842	Closed	-$562K	–	117
2014 Q3	$562K	Buy	+3,842	New	+$593K	0.12%	116
2013 Q4	–	Sell	-19,873	Closed	-$3.36M	–	118
2013 Q3	$3.36M	Sell	19,873 -2,766	-12%	-$429K	0.75%	66
2013 Q2	$3.43M	Buy	+22,639	New	+$3.21M	0.76%	60

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Tygh Capital Management's CLB Position: Q4 2019 in Review

Tygh Capital Management sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 39,178 shares — an estimated $1.83M sold.

Tygh Capital Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $3.43M in Q2 2013. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Tygh Capital Management reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Tygh Capital Management sold 39,178 Core Laboratories shares in Q4 2019, an estimated $1.83M.
Tygh Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Tygh Capital Management's Core Laboratories position peaked at $3.43M in Q2 2013.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Tygh Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.